| DevotedDOc | Addiction, Telemedicine & Health Economics

By DevotedDOc
Physician-Led Virtual Addiction & Reentry Care

Introduction

Opioid use disorder (OUD) remains one of the most expensive and yet preventable public health crises in the United States. Beyond the profound human cost, untreated OUD, in turn, drives an enormous medical, social, and economic burden for patients, families, employers, and healthcare systems alike.

Against this backdrop, at DevotedDOc, we see this reality every day. At the same time, however, we also see something else: as a result, when evidence-based treatment is delivered early, consistently, and without unnecessary barriers, outcomes reliably improve and costs decline dramatically.

As a result, telehealth has therefore emerged as one of the most effective tools to achieve this.

The Hidden Costs of Untreated Opioid Use Disorder

On the surface, initially, the direct medical cost of treating OUD with medications such as buprenorphine, methadone, or naltrexone is often cited as a barrier. Annual treatment costs can range from $6,000 to $14,000 per patient.

However, this framing ultimately ignores the far greater costs of not treating OUD.

Untreated or poorly managed OUD is associated with:

• Recurrent emergency department visits
  
• Hospitalizations for overdose and infections
  
• Psychiatric crises and suicide risk
  
• Incarceration and legal system involvement
  
• Lost productivity and workforce attrition
  

Nationally, opioid-related illness and overdose generate tens of billions of dollars in healthcare costs each year, with hospitals alone absorbing billions in uncompensated and preventable care.

From a health-economics perspective, lack of access not treatment is the most expensive option.

Why Telehealth Changes the Cost Equation

In practice, telemedicine fundamentally alters how and when patients access care. For OUD treatment in particular, this shift is especially impactful.

Telehealth reduces costs by:

• Eliminating transportation and missed-work barriers
  
• Allowing earlier initiation of treatment
  
• Improving appointment adherence and continuity
  
• Reducing reliance on emergency and inpatient care
  
• Supporting long-term retention in evidence-based treatment
  

Consistently, clinical data show that patients who remain engaged in medication-assisted treatment (MAT) experience lower relapse rates, fewer overdoses, and significantly reduced healthcare utilization.

Treatment Adherence Is the Real Cost Driver

The strongest predictor of lower healthcare costs in OUD care is treatment adherence.

Patients who remain adherent to buprenorphine-based treatment experience:

• Fewer emergency department visits
  
• Lower rates of nonfatal overdose
  
• Reduced inpatient admissions
  
• Improved medical and psychiatric stability
  

Accordingly Moreover, multiple payer and health-system studies demonstrate that adherent patients cost $18,000–$25,000 less per year than those who disengage from care or never initiate treatment at all.

Telehealth improves adherence by meeting patients where they are clinically, geographically, and socially.

A Physician-Led Telehealth Model Matters

Not all telehealth programs are the same.

At DevotedDOc, our model is:

• Physician-owned and clinician-led
  
• Built on clinical informatics, PDMP integration, and regulatory compliance
  
• Designed for continuity of care, not episodic prescribing
  
• Structured to support long-term stabilization, not volume-based metrics
  

Our care teams include emergency physicians, addiction-experienced clinicians, and regional medical directors who understand the downstream consequences of untreated OUD from overdose risk to incarceration and reentry failures.

This clinical rigor is what allows telehealth to reduce costs without compromising safety or quality.

Telehealth, Employers, and Institutions

For employers, correctional systems, and public entities, the financial impact of untreated OUD extends beyond healthcare claims.

Telehealth-based OUD treatment reduces:

• Absenteeism and presenteeism
  
• Workplace injuries and turnover
  
• Repeat offenses and the costs of returning to jail or prison
  
• significantly reduced use of healthcare services
  

As a result, when treatment is accessible, private, and timely, individuals are more likely to remain productive, engaged, and stable.

The Bigger Picture: Prevention Through Access

The best way to reduce costs is to prevent overdoses before they happen.

Telemedicine enables:

• Most importantly, earlier intervention before crisis points
  
• Rapid follow-up after ED visits or incarceration
  
• As a result, continuity during high-risk transitions (release, job loss, relocation)
  

From a from a public health view, telehealth is not simply a convenience, it is a cost-containment and mortality-reduction strategy.

Final Thoughts: Lower Costs, Better Outcomes

Opioid use disorder is a chronic medical condition. Treating it late, treated not consistently, or punitively drives costs up and outcomes down.

By contrast, telehealth, when delivered by a physician-led, clinically accountable organization, does the opposite.

At DevotedDOc, we believe reducing costs starts with reducing barriers. Ultimately, when patients can access care early, stay engaged, and receive medically necessary sound treatment, everyone benefits patients, families, employers, and the healthcare system as a whole.

 – DevotedDOc
Physician-Led Virtual Addiction & Reentry Care
Serving Florida, Georgia, New Mexico, Oklahoma, and beyond

Medically Reviewed By